Barclays Maintains Overweight on Acadia Healthcare Co, Lowers Price Target to $76
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Andrew Mok maintains an Overweight rating on Acadia Healthcare Co (NASDAQ:ACHC) but lowers the price target from $83 to $76.
September 30, 2024 | 3:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Barclays analyst Andrew Mok maintains an Overweight rating on Acadia Healthcare Co but lowers the price target from $83 to $76.
The Overweight rating suggests a positive outlook, but the lowered price target indicates a tempered expectation of growth. This mixed signal may result in a neutral short-term impact on ACHC's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100